Your browser doesn't support javascript.
loading
Defective tubulin detyrosination causes structural brain abnormalities with cognitive deficiency in humans and mice.
Pagnamenta, Alistair T; Heemeryck, Pierre; Martin, Hilary C; Bosc, Christophe; Peris, Leticia; Uszynski, Ivy; Gory-Fauré, Sylvie; Couly, Simon; Deshpande, Charu; Siddiqui, Ata; Elmonairy, Alaa A; Jayawant, Sandeep; Murthy, Sarada; Walker, Ian; Loong, Lucy; Bauer, Peter; Vossier, Frédérique; Denarier, Eric; Maurice, Tangui; Barbier, Emmanuel L; Deloulme, Jean-Christophe; Taylor, Jenny C; Blair, Edward M; Andrieux, Annie; Moutin, Marie-Jo.
Afiliação
  • Pagnamenta AT; NIHR Oxford BRC, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Heemeryck P; Grenoble Institut Neurosciences, Université Grenoble Alpes, Inserm, U1216, CEA, CNRS, 38000 Grenoble, France.
  • Martin HC; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
  • Bosc C; Grenoble Institut Neurosciences, Université Grenoble Alpes, Inserm, U1216, CEA, CNRS, 38000 Grenoble, France.
  • Peris L; Grenoble Institut Neurosciences, Université Grenoble Alpes, Inserm, U1216, CEA, CNRS, 38000 Grenoble, France.
  • Uszynski I; Grenoble Institut Neurosciences, Université Grenoble Alpes, Inserm, U1216, CEA, CNRS, 38000 Grenoble, France.
  • Gory-Fauré S; Grenoble Institut Neurosciences, Université Grenoble Alpes, Inserm, U1216, CEA, CNRS, 38000 Grenoble, France.
  • Couly S; MMDN, Université de Montpellier, INSERM, EPHE, UMR_S1198, Montpellier, France.
  • Deshpande C; South East Thames Regional Genetics Unit, Guys and St Thomas NHS Trust, London, UK.
  • Siddiqui A; Department of Neuroradiology, Kings College Hospital, Denmark Hill, London SE5 9RS, UK.
  • Elmonairy AA; Ministry of Health, Kuwait Medical Genetics Center, Sulaibikhat 80901, Kuwait.
  • Jayawant S; Department of Paediatric Neurology, John Radcliffe Hospital, Oxford, UK.
  • Murthy S; Community Paediatrics, Upton Hospital, Slough, UK.
  • Walker I; Clinical Biochemistry, Wexham Park Hospital, Slough, UK.
  • Loong L; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Bauer P; Centogene AG, 18055 Rostock, Germany.
  • Vossier F; Grenoble Institut Neurosciences, Université Grenoble Alpes, Inserm, U1216, CEA, CNRS, 38000 Grenoble, France.
  • Denarier E; Grenoble Institut Neurosciences, Université Grenoble Alpes, Inserm, U1216, CEA, CNRS, 38000 Grenoble, France.
  • Maurice T; MMDN, Université de Montpellier, INSERM, EPHE, UMR_S1198, Montpellier, France.
  • Barbier EL; Grenoble Institut Neurosciences, Université Grenoble Alpes, Inserm, U1216, CEA, CNRS, 38000 Grenoble, France.
  • Deloulme JC; Grenoble Institut Neurosciences, Université Grenoble Alpes, Inserm, U1216, CEA, CNRS, 38000 Grenoble, France.
  • Taylor JC; NIHR Oxford BRC, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Blair EM; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Andrieux A; Grenoble Institut Neurosciences, Université Grenoble Alpes, Inserm, U1216, CEA, CNRS, 38000 Grenoble, France.
  • Moutin MJ; Grenoble Institut Neurosciences, Université Grenoble Alpes, Inserm, U1216, CEA, CNRS, 38000 Grenoble, France.
Hum Mol Genet ; 28(20): 3391-3405, 2019 10 15.
Article em En | MEDLINE | ID: mdl-31363758
ABSTRACT
Reversible detyrosination of tubulin, the building block of microtubules, is crucial for neuronal physiology. Enzymes responsible for detyrosination were recently identified as complexes of vasohibins (VASHs) one or two with small VASH-binding protein (SVBP). Here we report three consanguineous families, each containing multiple individuals with biallelic inactivation of SVBP caused by truncating variants (p.Q28* and p.K13Nfs*18). Affected individuals show brain abnormalities with microcephaly, intellectual disability and delayed gross motor and speech development. Immunoblot testing in cells with pathogenic SVBP variants demonstrated that the encoded proteins were unstable and non-functional, resulting in a complete loss of VASH detyrosination activity. Svbp knockout mice exhibit drastic accumulation of tyrosinated tubulin and a reduction of detyrosinated tubulin in brain tissue. Similar alterations in tubulin tyrosination levels were observed in cultured neurons and associated with defects in axonal differentiation and architecture. Morphological analysis of the Svbp knockout mouse brains by anatomical magnetic resonance imaging showed a broad impact of SVBP loss, with a 7% brain volume decrease, numerous structural defects and a 30% reduction of some white matter tracts. Svbp knockout mice display behavioural defects, including mild hyperactivity, lower anxiety and impaired social behaviour. They do not, however, show prominent memory defects. Thus, SVBP-deficient mice recapitulate several features observed in human patients. Altogether, our data demonstrate that deleterious variants in SVBP cause this neurodevelopmental pathology, by leading to a major change in brain tubulin tyrosination and alteration of microtubule dynamics and neuron physiology.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tubulina (Proteína) / Encéfalo / Proteínas de Ciclo Celular / Neurônios Tipo de estudo: Etiology_studies Limite: Animals / Female / Humans Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tubulina (Proteína) / Encéfalo / Proteínas de Ciclo Celular / Neurônios Tipo de estudo: Etiology_studies Limite: Animals / Female / Humans Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
...